Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005

Go back to Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005
(NASDAQ: SEEL) Delayed: 1.28 --0 (-0%)
Previous Close $1.28    52 Week High $ 
Open $1.28    52 Week Low $ 
Day High $1.28    P/E N/A 
Day Low $1.28    EPS $ 
Volume 113,830